Abstract
In 2011, the year that subtypes of ANCA-associated vasculitis (AAV) were officially renamed according to key pathological characteristics, important progress was made not only in differentiating these subtypes, but also in understanding—and treating—their eponymous manifestations.
MeSH terms
-
Antibodies, Antineutrophil Cytoplasmic / blood*
-
Antibodies, Monoclonal, Murine-Derived / therapeutic use
-
Granulomatosis with Polyangiitis / blood
-
Granulomatosis with Polyangiitis / classification
-
Granulomatosis with Polyangiitis / diagnosis*
-
Granulomatosis with Polyangiitis / drug therapy
-
Humans
-
Immunologic Factors / therapeutic use
-
Neural Networks, Computer
-
Rituximab
-
Terminology as Topic*
-
Vasculitis / blood
-
Vasculitis / classification
-
Vasculitis / diagnosis*
-
Vasculitis / drug therapy
Substances
-
Antibodies, Antineutrophil Cytoplasmic
-
Antibodies, Monoclonal, Murine-Derived
-
Immunologic Factors
-
Rituximab